Correspondence Volume 121 | Issue 11-12 | Nov-Dec 2013
Environ Health Perspect; DOI:10.1289/ehp.1307424
Exposure Conditions and Pharmacokinetic Principles: Interpreting Bisphenol A Absorption in the Canine Oral Cavity
Justin G. Teeguarden,1 Jeffrey W. Fisher,2 Daniel R. Doerge2
1Pacific Northwest National Laboratory, Richland, Washington, USA; 2National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, Arkansas, USA, E-mail: email@example.com
Citation: Teeguarden JG, Fisher JW, Doerge DR. 2013. Exposure conditions and pharmacokinetic principles: interpreting bisphenol A absorption in the canine oral cavity [Letter]. Environ Health Perspect 121:A323; http://dx.doi.org/10.1289/ehp.1307424
J.G.T. has received grants from the U.S. Environmental Protection Agency, the National Institute for Occupational Safety and Health, and the American Chemistry Council. J.W.F. and D.R.D. declare they have no actual or potential competing financial interests.
Published: 1 December 2013
Gayrard et al. (2013) reported significant (~ 80%) absorption of bisphenol A (BPA) from solutions applied to the oral cavity of dogs, leading to higher serum BPA (aglycone) concentrations than occurred when BPA was absorbed through the gastrointestinal tract. This finding is consistent with first principles and experience with orally absorbed drugs. The implications for human exposure and health will be clear when experimental evidence is available regarding the extent and frequency of sublingual absorption in orally exposed humans.
Arguments made by Gayrard et al. that “nanograms-per-milliliter” serum concentrations of BPA resulting from sublingual absorption are plausible in humans ignore key pharmacokinetic and exposure data and conflate issues of serum BPA concentrations with serum BPA/BPAG (BPA glucuronide) ratios.
For a given dose, bolus dosing yields peak concentrations of a parent compound that are higher than those with nonbolus dosing. Peak concentrations in mixed systemic serum following sublingual exposure cannot exceed those following intraveneous (iv) dosing. Therefore, in humans, peak systemic serum concentrations following sublingual exposure cannot be higher than those resulting from bolus iv administration of a given BPA dose. Scaling by dose from pharmacokinetic studies of nonhuman primates (Patterson et al. 2013), the human serum concentration of aglycone BPA immediately after an iv bolus administration of a dose equivalent to a 95th percentile of aggregate daily U.S. human exposure (0.22 μg/kg body weight; Lakind and Naiman 2010) would be < 0.1 ng/mL, which is below current quantification limits (LOQ) using state-of-the-art technology. Therefore, peak systemic serum concentrations of aglycone BPA following sublingual exposure/absorption of this dose would also be < LOQ. This result is consistent with the data of Gayrard et al. (2013) in which dog serum BPA concentrations would be ~ 0.07 ng/mL (i.e., < LOQ) when sampled from a site reflecting systemic exposure (e.g., leg vein). Therefore, in 95% of the U.S. population, serum aglycone BPA concentrations of nanograms per milliliter are not possible, even with complete sublingual absorption.
Several studies in the literature have reported BPA/BPAG ratios in human serum samples higher than those (< 1%) consistently observed in human and animal oral pharmacokinetic studies (Vandenberg et al. 2007). Gayrard et al. (2013) introduced a new hypothesis (i.e., sublingual exposure/absorption) to justify this discrepancy. Previously proffered hypotheses for high BPA and BPA/BPAG ratios in human serum samples included exposures 10,000 times higher (Vandenberg et al. 2007) than those measured in humans (Lakind and Naiman 2010), extensive dermal exposure/absorption (Vandenberg et al. 2013), and sample contamination (Teeguarden et al. 2011). Only the latter hypothesis is supported by ample evidence that contamination of blood samples is not only common, but difficult to avoid (Ye et al. 2013).
Finally, extrapolation of BPA levels from BPAG levels using the measured ratio of < 1% following ingestion of BPA is appropriate under conditions where BPA reaches the systemic blood via gastrointestinal tract absorption [e.g., food (see Teeguarden et al. 2011)]. Similarly, values of approximately 10–20% would be valid for serum levels 0–4 hr after iv dosing or complete sublingual absorption, when sampled from a site representing systemic exposure.
Gayrard V, Lacroix MZ, Collet SH, Viguié C, Bousquet-Melou A, Toutain PL, et al. 2013. High bioavailability of bisphenol A from sublingual exposure. Environ Health Perspect 121:951–956; doi:10.1289/ehp.1206339.
Patterson TA, Twaddle NC, Roegge CS, Callicott RJ, Fisher JW, Doerge DR. 2013. Concurrent determination of bisphenol A pharmacokinetics in maternal and fetal rhesus monkeys. Toxicol Appl Pharmacol 267:41–48.
Ye X, Zhou X, Hennings R, Kramer J, Calafat AM. 2013. Potential external contamination with bisphenol A and other ubiquitous organic environmental chemicals during biomonitoring analysis: an elusive laboratory challenge. Environ Health Perspect 121:283–286; doi:10.1289/ ehp.1206093.
ISEE 2015 Abstracts Now AvailableEHP is pleased to present the abstracts for the 2015 annual conference of the International Society for Environmental Epidemiology (ISEE), “Addressing Environmental Health Inequalities,” being held 30 August–3 September 2015 in São Paulo, Brazil.
New Editor-in-ChiefWe are pleased to announce that Sally Perreault Darney has been selected as the new Editor-in-Chief of EHP. Sally comes to EHP from the U.S. Environmental Protection Agency, where she most recently co-led a large research project focused on assessing health disparities in vulnerable groups and providing healthy environments for children. Learn more about Sally and her vision for the journal in the September issue of EHP.
CEHN August 2015 Article of the Month“Ambient Heat and Sudden Infant Death: A Case-Crossover Study Spanning 30 years in Montreal, Canada” (DOI:10.1289/ehp.1307960) has been selected by the Children’s Environmental Health Network (CEHN) as its August 2015 Article of the Month. These CEHN summaries discuss the potential policy implications of current children’s environmental health research.
Sign Up to Receive E-mail Alerts
Recent Advance Publications
Prenatal Ambient Air Pollution, Placental Mitochondrial DNA Content, and Birth Weight in the INMA (Spain) and ENVIRONAGE (Belgium) Birth Cohorts
Endocrine-Disrupting Chemicals and Oil and Natural Gas Operations: Potential Environmental Contamination and Recommendations to Assess Complex Environmental Mixtures
Bisphenol A, Bisphenol S, and 4-Hydroxyphenyl 4-Isoprooxyphenylsulfone (BPSIP) in Urine and Blood of Cashiers
Prenatal Phthalate Exposures and Childhood Fat Mass in a New York City Cohort
Effects of in Utero Exposure to Arsenic during the Second Half of Gestation on Reproductive End Points and Metabolic Parameters in Female CD-1 Mice